Shares are again attractive even with weak Chinese macro, with P/E at just 22x, EBIT rebounding in 2023 and China NE sales becoming less key.
Very good company. In my portfolio since October 2022. I share your assessment, hoping for a little more, 14% p/a.
Kone: Upgrade to Buy on Better Earnings & Lower Share Price
Very good company. In my portfolio since October 2022. I share your assessment, hoping for a little more, 14% p/a.